US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 7.390
  • +0.060+0.82%
Close Mar 4 16:00 ET
  • 7.400
  • +0.010+0.14%
Post 19:52 ET
394.45MMarket Cap-3.47P/E (TTM)

Zevra Therapeutics Key Stats

Zevra Therapeutics Q4 2024 Estimates Date

Currency:USDMar 11, 2025

Estimate YoY
Revenue
8.93M
-32.47%
EPS
-0.40
-0.95%
Strong Buy

Feb 28, 2025

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.015M--
Mar 11, 20252024/Q4-- / 8.926M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.015M--
Mar 11, 20252024/Q4-- / 8.926M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data